top of page

Scientific studies on mRNA

Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign, A Report of Two Cases

Oncology

Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine, incidence assessed by 18F FDG PET-CT and relevance to study interpretation

Oncology

Hypermetabolic lymphadenopathy following the administration of COVID-19 vaccine and immunotherapy in a lung cancer patient, a case report

Oncology

Imaging of COVID-19 Vaccination at FDG PET CT

Oncology

Immune Response Visualized In Vivo by 18F-FDG PET CT after COVID-19 Vaccine.

Oncology

Immune Thrombotic Thrombocytopenic Purpura following Pfizer-BioNTech anti-COVID-19 vaccination in a patient healed from lymphoma after allogeneic hematopoietic stem cell transplantation

Oncology

Increased FluoroDeoxyGlucose (FDG) Avidity Following COVID-19 Vaccination

Oncology

Intensity of hypermetabolic axillary lymph nodes in oncologic patients in relation to timeline following COVID-19 vaccination

Oncology

Ipsilateral avid axillary lymph node update at FDG PET CT persists in 29% of patients 7-10 weeks after 2nd dose

Oncology

Ipsilateral Axillary Adenopathy from mRNA COVID-19 Vaccines

Oncology

Ipsilateral Malignant Axillary Lymphadenopathy and Contralateral Reactive Lymph Nodes in a COVID-19 Vaccine Recipient With Breast Cancer

Oncology

Isolated breast parenchymal changes following COVID-19 vaccine booster

Oncology

Kikuchi-Fujimoto disease can present as delayed lymphadenopathy after COVID-19 vaccination

Oncology

Kikuchi-Fujimoto disease following SARS CoV2 vaccination, Case report

Oncology

Kikuchi-Fujimoto Disease Post COVID-19 Vaccination, Case Report and Review of Literature

Oncology

Kikuchi-Fujimoto-like lymphadenopathy following COVID-19 vaccine, diagnosis and management

Oncology

Lessons Learned from Post-COVID-19 Vaccination PET CT Studies

Oncology

Lymphadenopathy after BNT162b2 Covid-19 Vaccine, Preliminary Ultrasound Findings

Oncology

Lymphadenopathy after the third Covid-19 vaccine.

Oncology

Lymphadenopathy Associated With the COVID-19 Vaccine

Oncology
bottom of page